DrugPatentWatch Database Preview

CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE Drug Patent Profile

Email this page to a colleague

« Back to Dashboard

When do Chlordiazepoxide Hydrochloride And Clidinium Bromide patents expire, and when can generic versions of Chlordiazepoxide Hydrochloride And Clidinium Bromide launch?

Chlordiazepoxide Hydrochloride And Clidinium Bromide is a drug marketed by Alkem Labs Ltd, Amneal, Dr Reddys, Misemer, Nuvo Pharms Inc, Pharma Life, and Teva Pharms Usa. and is included in seven NDAs.

The generic ingredient in CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE is chlordiazepoxide hydrochloride; clidinium bromide. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the chlordiazepoxide hydrochloride; clidinium bromide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Chlordiazepoxide Hydrochloride And Clidinium Bromide

A generic version of CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE was approved as chlordiazepoxide hydrochloride; clidinium bromide by NUVO PHARMS INC on July 7^th, 2020.

Summary for CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE

US Patents:	0
Applicants:	7
NDAs:	7
Finished Product Suppliers / Packagers:	9
Formulation / Manufacturing:	see details
What excipients (inactive ingredients) are in CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE?	CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE excipients list
DailyMed Link:	CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE at DailyMed

Pharmacology for CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE

Drug Class	Anticholinergic Benzodiazepine
Mechanism of Action	Cholinergic Antagonists
Physiological Effect	Decreased Parasympathetic Acetylcholine Activity Digestive/GI System Activity Alteration GI Motility Alteration

Anatomical Therapeutic Chemical (ATC) Classes for CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE

N05BA	Benzodiazepine derivatives
N05B	ANXIOLYTICS
N05	PSYCHOLEPTICS
N	Nervous system

US Patents and Regulatory Information for CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE

CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE is protected by zero US patents and one FDA Regulatory Exclusivity.

FDA Regulatory Exclusivity protecting CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alkem Labs Ltd	CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE	chlordiazepoxide hydrochloride; clidinium bromide	CAPSULE;ORAL	214065-001	Apr 26, 2021	AB	RX	No	No
Teva Pharms Usa	CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE	chlordiazepoxide hydrochloride; clidinium bromide	CAPSULE;ORAL	211476-001	Nov 2, 2021	AB	RX	No	No
Misemer	CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE	chlordiazepoxide hydrochloride; clidinium bromide	CAPSULE;ORAL	210579-001	Jul 29, 2020	AB	RX	No	No
Amneal	CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE	chlordiazepoxide hydrochloride; clidinium bromide	CAPSULE;ORAL	215555-001	Oct 25, 2021	AB	RX	No	No
Dr Reddys	CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE	chlordiazepoxide hydrochloride; clidinium bromide	CAPSULE;ORAL	214698-001	May 10, 2021	AB	RX	No	No